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ABSTRACT 
During the last ten years, there has been an increasing 
awareness of sporadic cases of Primary Amoebic Meningo-encephalitis 
(PAM) affecting primarily younger age groups and appearing in an acute 
fulminant form. The earliest positive case (Willaert, 1974) may have 
been in England in 1909 which shows that the disease has been with us 
for a long time. 
The pathogenic free-living amebae (PFLA), which comprises 
the genus Na egleria and the genus Acanthamoeba, are the causative 
organisms of PAM and AM*respectively. PAM is a rapidly fatal disease 
affecting the central nervous s ystem (CNS),the treatment of which to 
date has been successful in only a small number of cases, and 
therefore the continual screening of suitable chemotherapeutic agents 
against arnebae of the Naegleria spp. and Acantharnoeba spp.,is of great 
i mp ortance. 
AM is a lso essentially confined to the CNS althou gh it may 
take the form of chronic granulomata in the liver, spleen, uterus and 
kidneys (Martinez et al., 1977). 
ii 
Six chemotherapeutic agents: Ampho tericin B, 5-Fluorocytosine, 
Kanamycin, Oxy t et racycline, Tylosine and Levamisole were tested for 
activity a gainst a non-pathogenic and a pathogenic species of Naegleria 
and a non-pathogenic and a pathogenic species of Acanthamoeba in axenic 
culture. 
For the Naegleria spp., Amphotericin Band Oxytetracycline 
were found to be active and the Acanthamoeba spp. were found to be only 
susceptible to Levamisole. 
The s ynergistic combinations of drugs against the amebae were 
also investiga ted in axenic culture. In preliminary trials Kanamycin 
together with Oxy t etracycline showed promise against Naegleria fowleri 
(MsM) but thi s wa s later shown not to be the case. Amphotericin Bin 
combination wi th 5-Fluorocytosine was also shown not to be synergistic, 
however Amphotericin Bin combination with Oxytetracycline proved to be 
effective against N. fowleri. 
Amphotericin B was combined with 5-Fluorocytosine against 
A. culbertsoni (A-1) but was not found to be synergistically active. 
* Amebic menin gitis caused by Acanthamoeba infections. 
Levamisole was also tested against N. gruberi (Pl200f) and 
A. castellanii (0,1) at various stages in growth of the amebae (i.e. 
24, 48 and 72 hour stock cultures) to determine the effect of usi ng 
aged amebae. It was found that the age of the stock culture bore no 
relation to the activity of the drug. 
iii 
After axenic culture testing, the susceptibility of the 
pathogenic N. fowleri (MsM) and A. culbertsoni (A-1) to the a gents 
which showed activity, was investigated in a vero cell culture system. 
For N. fowleri (MsM) the results of axenic culture testing were 
confirmed,with Amphotericin Band Oxytetracycline protecting the 
monolayer from the destructive effects of the amebae,both when used 
singly and at a greater efficiency when added t ogether as a synergistic 
combination. 
Levamisole, although effective to some extent a ga inst 
Acanthamoeba spp. in ax enic culture,failed to show any activity a gainst 
the amebae in vero cell culture testing. 
In vivo animal protection studies were then performed using 
drugs that had been shown either in this or other studies to be 
effective against either Naegleria or Acanthamoeba spp. Chemotherapeutic 
agents tested on N. fowleri (MsM) included two i midazoles; Miconazole 
nitrate and Ketoconazole (previously known as R41,400), as well as 
Amphotericin B. The synergistic combination of Amphotericin B with 
either Tetracycline or Oxytetracycline was also investigated. 
For A. culbertsoni (A-1), 5-Fluorocytosine, and Polymyxin B 
were tried both singly and in combination. 
These drugs were injected by intraperitoneal (I.P.) and 
intraventricular (I.vent.) routes. The results were not promising, 
with none of the drugs offering significant protection even whilst 
using Amphotericin B which is considered the drug of choice. 
The question of adequate drug levels reaching the brain was 
tested out with two imidazoles, Ketoconazole and Miconazole. Serum 
samples were assayed against Candida pirapsilosis and C. pseudotropicalis 
respectively at various time intervals after innoculation with the drug, 
and a gradual increase and breakdown of the drug in the animal system 
could then be shown. These results showed that based on in vitro results, 
the levels of the imidazoles obtained in the serum after the first eight 
hours after injection,should have been sufficiently high to prevent 
amebic multiplication. 
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CHAPTER ONE: INTRODUCTION 
1.1 The History of the Free-living Amebae as Disease Agents 
The history of Pathogenic Free-living Arnebae (PFIA) of the 
genera Acanthamoeba and Naegleria has been extensively reviewed 
elsewhere (Culbertson, 1971; Duma et al., 1971; Chang, 1971, 1974a; 
Carter, 1972; Cursons, 1974; Cursons and Brown, 1976). 
The commonest disease caused by PFLA is Primary Amebic 
Meningo-encephalitis (PAM) caused by ameba quite different to those 
traditionally re garded a s parasitic in man,and are not ordinarily 
parasitic in lower animals. They are ubiquitous in the environment 
and are free-living in water, sewage, soil and other decaying organic 
rnatter(Carter, 1972). 
Willaert in 1974, tabulated 84 cases from all the continents 
with the exception of Antarctica. Since then at least 10 additional 
cases have been reported (Table 1 ) • 
Acanthamoeba spp. were the first agents implicated in this 
disease, but PAM is now known to be caused by a free-living arnebae of 
the genus Naegleria . This was due mainly to the first case prototype 
of this illness which was described by Fowler and Carter in 1965. In 
1968 Carter, Culbertson et al., and Butt et al., showed that the 
incriminating species of most reported cases belonged to the genus 
Naegleria, and in 1970 on the basis of morphological, cultural and 
pathogenicity differences Carter renamed the pathogeni c species 
Nae gleria fowleri distinguishing it from the non-pathogenic Naegleria 
gruberi . 
Prior to 1968, all cases of PAM were attributed to the 
Acanthamoeba spp. which was probably due to the pioneering work of 
Culbertson et al., (1958, 1959, 1965) who, whilst working on the 
production of polio vaccine found an ameba which contaminated the 
cultures of monkey kidney cells. These cultures, when innoculated 
intracerebrally into mice, produced a necroting, hemorrhagic meningo-
encephalitis that killed mice in 4-7 days. The re s pon s ible amebae was 
identified as an Acanthamoeba and they predicted on the basis of the 
finding, that this amebae could be capable of producing disease in 
humans. This ameba was previously considered to be a harmless free-
living organism. 
1 
The disease caused by PFLA can be divided into two entities 
(Chang, 1974 (a) ) : 
a) a swimming-associated acute rneningo-encephalitis known as 
Primary Amebic Meningo-encephalitis (PAM) (Martinez et al., 
1977). This is the most important of the two and is caused 
by Naegleria fowleri (non-pathogen - Naegleria gruberi) . 
Infection is thought to occur in two ways: 
i) Naegleria contaminated water may be introduced into the 
upper nasal passages; 
ii) it may be due to the washing of trophozoites residing in 
2 
the lower nasal passages of a carrier into the upper nasal area. 
A pathogenic strain of Naegleria was isolated from a normal 
healthy carrier (Visvesvara et al., 1974). 
b) a non-swimming-associated chronic meningo-encephalitis 
(Amebic Meningo-encephalitis (AM) caused by amebae of the 
Acanthamoeba/Hartmanella group . It is considered that the 
mos t probable species is A. rhysodes along with another 
pathogenic species A. culbertsoni. Amebic Meningo-encephalitis 
due to the involvement of the Central Nervous System (CNS), 
appears to be a secondary phenomenon representing metatastic 
spread from a primary focus in the skin, genitourinary tract 
or respiratory tract (Martinez et al., 1977). Cutaneous 
ulceration is a possible point of entry with hematogenous 
spread to the CNS and lower respiratory tract.Infections in 
experimental animals have been reported (Martinez et al.,) 
due to this spread. 
Subsequently Acanthamoeba spp. have been indicated in a number 
of chronic illnesses such as respiratory infections (Martinez et al., 
1975), corneal ulceration of the eye leading to blindness (Nadington 
et al., 1974; Visvesvara et al., 1974) and together with Naegleria spp. 
in humidifier disease (M.R.C. Symposium, 1977). The reidentification of 
the etiological agents of the 1968 cases of PAM in New Zealand as 
N. fowleri species (Cursons and Brown, 1975, 1976) has dismissed the 
notion of slime moulds in the etiology of PAM (Mandel et al., 1970). 
Henceforth, in the text, the nomenclature of Martinez et al., 
1977, of PAM for Naegleria infections and AM for Acanthamoeba meningo-
encephalitis will be adopted. 
1.2 Classification 
Study of the basic classifi ca tion of the small free-living 
amebae ha s been stimulated by the di s covery of their role in human 
disease. Carter (1970) accepted the decision of Page to retain the 
family designation of Vahlkampfiidae (for Nae gleria spp.) in 
preference to the revision by Singh and Das (1970). Recent studies by 
Fulton (1970) and more recently by Schuster (1975) on the mitosis of 
Naegleria and related amebae displaying promitosis,have affirmed the 
lack of validity of details such as "interzonal body" and "polar caps" 
for use in establishing a higher taxa such as Schi zopyrenidae. These 
points and others are extensively reviewed elsewhere by others (Page, 
1974; Chang, 1971; Schuster, 1975; Visvesvara et al., 1975). 
In reviewing Acanthamoeba spp. it was clear that they shoul d 
be moved from the Hartmanellidae and related limax ameba e. Page (1967) 
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for one, proposed the replacement of the Acanthamoeba e in the Mayorellidae. 
In a recent review by Cursons and Brown (1976) the controversy 
regarding the classification of the PFLA appeared to be settled with the 
majority preferring Chang's 1971 classification scheme. The identifi-
cation of isolates involves the exploitation of specific cytolo gica l, 
morphological, physiolo gical, immunological, growth and pathogenicity 
characteristics in an ordered sequence readily usab le by hospita l and 
public health laboratory staff (Cursons and Brown, 1976). 
1.3 Occurrence and Distribution 
The ability of PFLA to form resistant cysts undoubtedly 
enables them not only to withstand unfavourable conditions, e.g. the 
isolation of Acanthamoeba spp. from 2°c (Brown and Cursons, 1977) and 
from Antarctic soils (Brown et al., pers. comm.), but also to take 
advantage of the intermittent occurrence of favourable condition s . 
The PFLA appear to be truly ubiquitous organisms, as isolations have 
been recorded from a variety of environmental sources such as a ir 
(Kingston and ~arhurst , 1968), humidifier systems (M.R.C. Symposi um, 
1977), freshwater, brackish and ocean systems (De Jonckheere et a l ., 
1975; Brown and Cursons, 1977; Stevens et al., 1977a; Wellings c t al., 
1977), chlorinated swimming and domestic waters (Cerva, 1971a; 
Anderson and Jamieson, 1977; Cerva and Huldt, 1974), from bottled 
drinking water (Desmet-Faix, 1974), from a home dialysis unit 
(Casemore, 1977), from soil (Anderson and Jamieson, 1972; Cursons 
et al., 1978b), and from sewage (Singh and Das, 1972; Chang, 1974a) 
Isolations have also been recorded from cell cultures (Jahnes e t al., 
1957; Stevens and O'Dell , 1973a ; Willaert e t al ., 1978~ throat and 
nasa l cavities (Elridge and Tobin, 1967; Cerva et al., 1973; Chang 
e t al ., 1975), eye inf e c tions (Nagington et al., 1974; Visvesvara et al. , 
1975) , gastrointestinal washings (Hoeff l er and Rubel, 1974) , cold-
blooded vertebrates (Frank, 1974 ) , snails (Kingston a nd Taylor, 19 76) , 
and fish (Taylor, 1977). 
Temperature and pH a re equally t olerated over a wide range 
wi th in vitro growth r epor ted up to 45°c (Griffin, 1972) and a pH range 
of 4.6 to 9.5 (Carter, 1970). 
The dis tribution of the pa thogenic species in relation t o 
non-pathogenic ones is s till unknown (Cursons, 1978) though i n general, 
non-pa t hogenic species are more prevalent at ambient temperature in 
tempera te zones . The r epeated i so l ations of PFLA from waters above 
ambient temperatur e , i .e. grea ter or equal to 30°c (De Jonckheere et al., 
1975 ; Stevens et al ., 1977a; Welli ngs et al ., 1977 ; Cursons et a l., 
1978b) , combined with their higher optimum temperature of growth 
(Griffith, 1972 ) suggests that the pathogenic amebae are environmentally 
selected over non-pathogenic amebae in waters above ambien t temperature . 
The source of the pathogenic arnebae in these waters is unknown though 
the fac t that Cursons e t al. (1978b), and Wellings et a l. (1977) have 
isolated PFLA from the soil , which is the preferred habitat of small 
free-l i ving arnebae (Singh, 1978) , makes it possib l e that the soil ac t s 
as a ~0 servoir of pathogens in t he same way as it does fo r Cryptococcus , 
and t ha t contamination occurs via run off af ter rain (Cursons, 19 78) . 
1.4 Pathogenic ity 
The invasion of or gans and tissues b y PFLA is now well 
documen ted (Culbertson e t al ., 1959, 1968, 1972; Carter, 1968 , 1970, 
19 72; Callicot e t al. , 1968; Chang , 1971, 1974a & b, 1976; 
Cul'bc- t son, 1971; Martinez et al. , 1973, 1975, 1977 ; Visvesvar a and 
Bal a~u t h, 1975; Wong et al. , 1975 a & b). The CNS i nvasion by 
Na e~lPria spp . occurs primarily via the nasal mucosal epithelium, 
ma i~l ) due to the pathological condition of the cribriform plate and 
subjacent nasal passages (Culbertson, 1971; Carter, 1972) and this has 
been verified experimentally by Martinez et al. (1973). Using mice 
they s howed that amebic invasion occurs through the disruption of the 
olfactory mucosa , penetration into the submucosal plexus , probably by 
phagocytosis by the ameba~ of the s ustentacular cells of the olfactory 
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neuroepithelium,and finally through the cribriform plate to the CNS. 
In cases of Acanthamoeb a meningo-encephalitis,the involvement 
of the CNS appears to be a secondary phenomenon representing metatastic 
spread from a primary focus in the skin, geni tourinary or respiratory 
tract (Martinez et al., 1975, 1977; Culbert son, 1971). Martinez et al. 
(1975) reported lower respiratory tract infections in experimental 
animals. 
AM . due to Acanthamoeba spp.,appears to be due to an 
opportunistic infection of the CNS. AM occurs in patients who are 
chronically ill, debilitated or in those whose cell mediated immune 
responses have been impaired as a result of either underlying sys temi c 
disease or its treatment by i mmunosuppressive me thods (Kernohan et al., 
1960; Jager and Stamm, 1972; Robert and Rorke , 1973; Bhagwandeen et al., 
1975). 
Acanthamoeba infections of sites with reduced accessibility 
to the immune s ystem (e.g. the e ye) also demonstrates the opportunistic 
nature of these infections . Isolations of Acanthamoeba from the cornea 
of the eye ( Nagington et al., 1974) were shown to be of low virulence 
and infection only resulted after damage to the cornea (Visvesvara et al., 
1975). 
Once CNS invasion has occurred, destruction of the surroundin g 
tissue is thought to be brou ght about by a combination of phagocytosis 
and pinocytosis of host tissu e by N. fowleri,and solely by pinocytosis 
in the case of A. culbertsoni (Visvesvara and Callaway, 1974; Maitra 
et al., 1974, 1976). The extensive reports of the possession of 
lysosomal and hydrolytic enzymes is reported elsewhere (Bowers and Korn, 
1973; Martinez et al., 1975; Chang, 1976; Maitra et al., 1976; Cursons 
and Brown, 1976), and it is also speculated that the levels of the 
cytopathic enzymes produced may explain the degrees of virulence amon g 
the Acanthamoeba and the ·N: fowleri isolates (Cursons, 1978; Culbertson, 
1971; De Jonckheere and van de Voorde, 1977b). 
1.5 IIIIlilunity 
Many authors have pondered over the low incidence of PAM a ~d 
AM cases with regards the ease and frequency of isolation of pathoge nic 
PFLA from the environment (Anderson and Jamieson, 1971; Cursons et al., 
1977b, 1977; John ·et al., 1977; Wellings et al., · 1977; Haggerty and 
John, 1978). This has led many to speculate on the existence of probable 
host related susceptibility factors and the demonstration of specific 
antibodies to free-living amebae in human sera has been reported (Chang 
a nd Owens, 1964; Edwards et a l . , 1976; Cursons et al., 1977; MRC 
Symposi um , 1977). 
Adams et al., (1976) reported that mice surviving a primary 
intravenous injection of N. fowleri we re subsequent l y resistant to further 
challenge by the same route with a dose of amebae that produced a 
unifo r mly fa t al disease in untreated con trol mice . It was fur ther 
demonstrated by this group tha t mice i mmunized with live or formalized 
N. fowleri or live N. gruberi either subcut aneously , intraperitoneally, 
intravenously o r intramuscularly were significantl y pr o tected agains t a 
subsequent challenge with N. fowleri (John et al . , 1977) . The role of 
cell mediated immunity (CMI) in r es i stance to infec t ion by N. fowleri 
was reported by Diffley et al. (19 76) , who demonstrated tha t guinea-pigs 
surviving a normally fata l chall enge with N. fowleri, exhibited a 
delayed hypersensitivity when t ested intradermall y with a soluble fraction 
derived from N. fowler i (Cursons et al . , 1977) . Thong (1978) s ta ted tha t 
protective i mmuni ty to PAM could be transfer red t o syngeneic mice by 
immune sera but no t by i mmune spleen cells . The i mmunity may be related 
to agglutinating antibodies demonstrated in immune sera or an t itoxic 
antibodies in immune sera may be the active principle . These all tend 
to support the hypo t hesi s tha t unwitting exposure to the more ubiquitous 
non-pathogenic N. gruberi may i mmunize against N. fowleri and the same may 
also occur with Acanthamoeba spp . The fact tha t some underlying immunity 
exists was dernor.strated by Wong et al. (1975 a & b) who demonstrated 
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tha t prima t es ~e re apparently immune t o intranasal or intravenous 
innoculations of N. fowler i or A. culbertsoni unless on i mmunosuppressive 
drugs. However intrathecal innoculations were shown t o cause arnebic 
meningo- encephalitis. Culbertson has shown tha t mice immunized with 
Acantharnoeba spp . are resistant to intranasal challenge with A. culbertsoni 
but was unable to show the same with Naegleria spp . 
1, 6 Control Measures 
Free- l iving amebae are widely dispersed in the environment a nd 
the fact that t hey can be isolated from chlorinated domestic and swimming 
waters (Cerv2 , ~971a; Anderson and J amieson, 1972; Cerva and Huldt, 1974; 
De Jonckheere and van de Voorde , 1976), as well as untreated recreationa l 
waters has led to an expression of concern by public health authorities 
over the possible contraction of PAM or AM via t hese sources . 
Cerva (1971a), afte r reviewing 16 fatal cases of PAM from an 
indoor chlorinated swimming pool stated that, there will always be the 
cons t ant presence of limax amebae even under the strict observations of 
all routine safety measures applied to swinnning pools and water systems. 
This was supported by a reported case of PAM in South Australia by 
Anderson and Jamieson (1972), in which the victim contracted the dis ease 
from domestic bath water, and that super chlorination to lOmg.1-l failed 
to eradicate Naegleria from the contaminated pool. However, Lyons and 
Kapur (1977) in a survey of 30 halogenated public swimming pools 
concluded that the low amebic densities (less than one per litre), in 
the majority of pools illustrated that these amebae could be adequately 
controlled by proper pool maintenance. The possession of resistant 
cysts however complicates the disinfection process. 
Derreumaux et al. (1974) demonstrated that O.Smg.1-l of H0Cl, 
the active disinfecting component of chlorine disinfection was able to 
eradicate both Naegleria and Acanthamoeba spp. De Jonckheere and van 
de Voorde (1976), showed that an initial concentration of chlorine 
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between 0.5 - l.Omg.1-l was cysticidal for Naegleria spp. but that 
Acanthamoeba culbertsoni cysts were not inactivated by levels up to 40mg.1-l. I 
In a study of alternative disinfectants by Cursons et al., 
(1978b) it was shown that deciquam 222, chlorine, chlorine dioxide and 
ozone a l l possessed potential disinfecting properties for PFLA, but at 
higher levels than those for disinfecting bacteria. Deciquam 222 was 
found to be the most effective followed by chlorine, chlorine dioxide 
and ozone, but the final choice of disinfectant mus t depend on the 
physical and chemical properties of the water to be treated. 
1 . 7 Dia gnosis 
Early diagnosis and treatment along with careful intensive 
care treatment therapy is extremely important in the treatment of 
infections due to PFLA; more in those caused by Naegleria spp. The 
survival of a nine year old female in Torrance, California (Siedel 
et al., pers. connn . 1978) and that of a fourteen year old male in 
Australia (Anderson and Jamieson, 1972) could be attributed to this. 
Fluid restriction, management of cerebral edema and other complications 
of amebic meningo-encephalitis are all important in the care of these 
patients (Siedel et al., pers. comm. 1978) . 
Infections due to Naegleria spp. are usually characterized by 
a previous history of swiunning in freshwater some 7-14 days before 
expressing typical meningitis symptoms (Cursons et al.,1977; Carter, 
1972; Chang, 1974a). The symptoms include severe headache (usually 
frontal), sore throat, nausea, vomiting, fever (39-41°C) accompanied 
by a stiff neck. Clinical isolation of amebae can be routinely done 
by cultivation of Cerebral Sninal Fluid (CSF), brain tissue or nasal 
discharge on Page 's Ameba Saline Agar spread with live E. coli or E. 
cloacae; by a xenic CYM culture ; or by passaging of suspected material 
through cell culture, at 37-45°C (Cur son s et al., 1978). The 
examination of CSF is still probably the mos t routine method of 
diagnosing general meningitis . The differences between amebic and 
bacterial meningitis are sli ght and although in positive amebic cases 
there tend to be a predominance of neutrophils in the CSF, a hi gh 
protein concentration and low sugar levels, complete dia gnosis relies 
on finding amebae in the fluid and the further cultivation of these for 
complete dia gnos is. Species identification can then be achieved by a 
method outlined by Cursons and Brown (1976). 
In post-mortem dia gnosis, a degree of encephalitis is 
invariably present. Severe brain swelling and redness, combined with 
purulent and haemorrhagic exudate containing numerous amebae is more 
extensive on the ventral surface of the cerebrum or cerebellum and over 
the brain stem. Amebae are also numerous in the olfactory nerve bundles 
which are virtually destroyed by purulent inflamma tion (Carter, 1969, 
1972). The grey ma tter of the cerebral hemispheres and cerebellum shows 
variable sized lesions which tend to be haemorrhagic and quite soft when 
they are large (Culbertson, 1971). Puralent meningitis is usually 
inconspicuous and confined to the antero-basal aspects of the brain, and 
it is only rarely tha t one can find inflammation or amebic invasion in 
the posterior cerebral hemispheres, brain stem or cerebellum, and never 
in the spinal cord (Carter, 1969, 1972). 
The Indirect Immuno Fluorescent Antibody (IFAB) technique 
applied to hydrosoluble protein extracts of either Naegleria or 
Acanthamoeba spp. is a valuable tool in the identification of species. 
It can also be app lied to identify amebae in brain sections of suspected 
or proven patients,though is a time consuming process and is not 
recommended for r outine laboratory practice. Antisera can be produced 
in rabbits and can be made species specific by suitable absorption 
methods. IFAB me thoc s can also be used to provide rapid screening 
methods for dete ction of PFLA in swimming pools, tap and other domestic 
and recreational ~a ter supplies. 
Immunoperoxidase methods have been used to demonstrate both 
Naegleria and Acanthamoeba spp. in brain sections of patients who have 
died from PAM and AM respectively by Culbertson (1975) and Cursons 
et al., (1976). This is a method that may be shown to be more valuable 
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in the future than immunofluorescence techniques. It has certain 
advantages over IFAB in that permanent preparations can be made, no 
specialized equipment is necessary and clear definitive staining of 
tissue elements results (Culbertson, 1975). 
Acanthamoeba meningitis infections are difficult to diagnose 
even in advanced cases due to the lack of specific s ymptoms and the 
apparent lack of amebae in the CSF (Chang, 1974a). There is usually a 
history of poor health and immunological incompetence with few patients 
giving a past history of swimming. The onset is slow (>10 days) and 
insidious,with the lung, brain and kidneys being infected (Martinez 
et al., 1976). Acanthamoeba infections may initially produce a severe 
bronchopneumonia, the organisms then dessimina ting and reaching the 
CNS via the bloodstream (Marino, 1975). 
Post-mortem diagnosis relies on the presence of superficial 
lesions in the grey matter with granulomatosis inflamma tio~ and the 
presence of trophozoites and double walled wrinkled cysts in apparently 
normal tissue bordering the lesion (Chang, 1974a; Carter, 1972; 
Culbertson, 1971; Hoffmann et al., 1978). Many authors re gard this as 
diagnostic of Acanthamoeba infections. 
In the case of eye infections reported by Nagin g ton et al. 
(1974) and Jones et al. (1975), positive diagnosis was possible b y 
taking corneal scrapings, with subsequent isolation and identification 
of Acanthamoeba spp. 
1. 8 PAM Cases and Their 'Treatment 
Since Willaert published the extensive review of world-wide 
cases due to PAM in 1974, there have been at least ten additional cases 
reported (Table I). Symmers (1969) reports a possible earliest case 
dating back to 1909. A later case reported by Derrick et al. (1948) 
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was originally thought to be due to Iodamoeba butschlii, but was later 
proven by fluorescent antibody staining to have been caused by N. fowleri 
(McMillan, 1977). The confusion in this case arose through the patient 
ha ~rj i!g ,,,widespread alimentary and systemic invasion as well as the 
typical pattern of cerebral invasion by morphologically identical amebae, 
thought to be caused by starvation of the patient, perhaps by reducing 
his gastric activity, bile secretion and amebicidal serum factor (Carter, 
1970). The reidentification of the etiological agents of the 1968 cases 
of PAM in New Zealand as ·N~ fowleri (Cursons and Brown, 1975; Cursons 
· ·et ·al., 196 7a) has dismissed the notion of slime l'l'Odds being involved in 
; NUMBER C.'\USATIVE 
COUNTRY YEAR OF CASES ORGANISM DI AGNOSIS TREATMENT OUTCOME REFERENCE 
. 1974 1 N. fowleri (MsT ) isolation Peni ci llin died Cur sons ~ ~-, 1976b 
NEW from CSF Ampicillin 
ZEALAND 
Amphotericin B 
1978 l Ii. fowleri (MsM) isolation Amphotericin B died Cursons e t ~., pers. 
from CSF comm ., 1978 
1974 l k!. fowleri (Lovell) isolation .Unknown died De Jonckheere, 1977 
from CSF 
1974 l Acanthamoeba sp, IFAB Steroids died Marti nez et .§.1., 1977 
U,S,A, Penicillin 
1975 l Acanthamoeba sp, IFAB Unknown died Hoffman ~ al. , 1978 
post- mortem 
1978 l Naegleria sp, isolation Amphote r ici n B survived Seidel g ,tl., pers, 
from CSF Miconazole co mm ,, 1978 
Rif ampi n 
VENEZUELA l !:. . cul berts oni IFAB Steroids died Martinez g ~., 1977 
1 A. cas tellanii IF.I\B Steroids died Marti nez ~ ~-, 19 77 PERU - Antibiotics 
1972 l Acanthamoeba sp. post-mortem Antibiotics died Bhagwand een ~ ~., ZAMBIA Amphotericin B 1975 
1958 l Acanthamoeba sp. post - mortem Penicillin died Ringsted ~ ~-, 1975 
KOREA Streptomycin 
Chloramphenicol 
Table I: Cases of Primary Amebic Meningo-encephalitis Reported After 1974 (modified from Cursons, 1978) 
_. 
0 
NUMBER CAU SATIVE 
COUNTRY YEAR OF CASES ORGANISM TREATMENT 
1968 l Naegleria Me tronidazole -
UGANDA Emeti ne - Penicillin 
Chloroquine , 
- 1967 1 A, ast ron::txis Ampicillin 
Peni cillin - G 
U.S.A. 1978 1 Naegl eria Amphotericin B 
~licona zo le 
Rifampin 
1970 2 Naegler ia Streptomycin 
Isonicoteinhydrosine 
INDIA Sulphadexanathosone Ampho t e ricin B 
1973 3 N. fowleri Unk.nown 
1969 2 Naeg leria Antibi otics 
ENGLAND Sulphadiazine 
Amphotericin B 
1971 1 !i . fowleri Amphotericin B AUSTRALIA Sulphadiazine 
Table II: Probable and Definite Survivors of Primar::t Arnebic Meningo-encephalitis 
REFERENCE 
Grundy & Blowers, 
1970 
Callicott~ iU:.•, 
1968 
Seidel g fil., pers. 
comm. 1978 
Pan & Ghosh, 1971 
S. R. Das, pers. comm, 
to Willaert (l974) 
Apley~~., 1970 
Anderson & Jamieson, 
19 72 
.... 
.... 
the etiology of PAM (Mandel e t al ., 1970). 
The drug treatment of PAM has been very discouraging with 
' 
Willaer t ' s summar y (1974) providing information of onl y ten possible 
survivors of the disease. The Californian case of Seidel et al . (1978) 
brings the world total to eleven cases (Table II). In the earlier 
cases , where the amebic nature of the disease had no t been suspec t ed, 
treatment consisted only of antibacteria l agents such as sulpha-drugs, 
penicillin, st r ep t omycin , tetracyclines and chloramphenicol (Fowler 
and Carter , 1965; But t et al ., 1968; Cerva and Novak , 1968 ; Dos Santos , 
1970 ; Van den Driessche e t a l., 197 3) . However, even in later cases 
where the antiprotozoal drugs emetine , chloroquine and metronidazole 
were often used, the course of the disease was not affected in the 
slightes t (Car ter, 1968, 1970, 1972; Duma et al. , 1971) except in the 
unproven case of Grundy and Blowers (1970) in which surviva l was 
attributed to chl oroquine . Naegleria were supposedly isola t ed from 
the CSF bu t fai l ed to survive for any length of time in cul t ure and 
subsequently were no t positively identified . The patient a lso 
presented atypical symptoms and tr eatment consisted of me tronidazole, 
emetine, penicillin su]phane and chloroquine . 
The in vitro activity of antibacterial agents agains t 
pathogenic Naegleria has been extensively reviewed by many (Carter, 
1969; Ma ndel et al . , 1970; Prasad, 1972 ; Thong et al ., 1977 ; Lee e t al. , 
1979 , Donald e t al ., 1979) . Of the antiprotozoal drugs , emetine 
hydrochl or ide was shown t o be effec tive in vitro against N. fowleri 
(Carter , 1969 ; Prasad , 1972 ; Das , 1975) although it does not protect 
animals from the disease (Culbertson et al . , 1968) , probably due to its 
inability t o pass the blood-brain barrier (Parmer and Cottrill, 1949) . 
Chloroquine and metronidazole have a lso been shown to be ineffec tive 
both in i n vitro and in vivo studies (Carter, 1969 ; Mandel et alt , 1970; 
Duma et al . , 1971). 
12 
Amphotericin B was the only drug to appear promising in the 
early 70's, and as can be seen in Table II, it was used in the trea t ment 
of all survivors except the unproven case of Grundy and Blowers (1976) 
and Callicott et al;, (1968) . Amphotericin Bis an antifungal polyene 
antibiotic and in vitro t es ts have shown it to be very effective against 
Naegleria spp. (Carter, 1969 ; Mandel et al., 1970; Duma et al . , 1971; 
Schuster and Rechthand, 1975 ; Visvesvara and Balamuth, 1975; Duma and 
Finley, 1976; De Jonckheere a nd van de Voorde, 1977 ; Donald et al., 1979) 
and t o show i n vivo promise (Culbertson et al . , 1968; Carter, 1969; 
Das 197 1; Thong, 1978 , 1979) . 
Carter (1969) suggested that amphotericin B be tried in the 
treatment of PAM by simultaneous intravenous and intraventricular 
administration . The doses recommended were: 0.25mg.kg- 1 1V and 1.0mg 
into the cerebral ventricles (I.vent.)in the first 24 hours which were 
as high as he dared propose due to the highly toxic nature of the drug. 
Carter (1972) also suggested using sulphadiazine as well as amphotericin 
B initially,in case the amebae should prove to be Acanthamoeba. These 
amebae have shown to be resistant to both these drugs in vitro (Casemore, 
1970; Chang, 1971; Visvesvara and Balamuth, 1975; Duma and Finley, 1976; 
Nagington and Richards, 1976; Donald et al ., 1979), but there is 
evidence to show that they are affected by sulphadiazine in vivo 
(Culbertson et al., 1965). Subsequently the treatment was tried on two 
patients in the U.S.A. (Duma et al., 1971) who were in the early stages 
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of the disease and should have responded. The first patient (patient 3, 
Duma et al., 1971) was given 1.5mg of amphotericin B through a ventricular 
tap which was repeated 16 hours later. 10mg amphotericin B was also 
administered I.vent. together with 10mg dexamethasone. The patient was 
also given 400mg metronidazole (orally); 200mg chloroquine base and 4mg 
dexamethazone intramuscularly (IM) every 6 hours. However, 72 hours 
after admission he became shocklike, respiration ceased and he died . 
The second patient (patient 4, Duma et al., 1971) received similar 
treatment though he died 66 hours after admission. 
Carter (1972) reported similar findings to Duma et al (1971) 
in two patients that had been treated in the same way (seventh and 
ninth patients Table III, Carter, 1972). There was also the added 
difficulty in getting the drug into the swollen brains by the intra-
ventricular method. 
Apley et al (1970) described three cases of PAM in Britain, 
two of which were diagnosed presumptively because of association with 
the fatal proven case. They had the same early symptoms, however, 
neither actually developed the convincing signs of meningitis . ·N; gruberi 
was cultured from the CSF of the child who died and from only one of the 
others. Amphotericin B was administered to the fatal case after finding 
amebae in the CSF. It was given IV in one daily dose of 0.25mg.kg-l 
given over three to four hours. This was increased to lmg.kg-l over one 
week, but the patient died on the sixteenth day after admission. It is 
interesting to note that on the seventh day after admission amebae were 
seen in the CSF though many appeared to be dead. By the eleventh day 
after admission, the CSF contained no amebae. It is also interesting 
that the drug was given py the intravenous route only, and yet produced 
high levels in the CSF, apparently destroying most of the amebae in the 
CNS. The patient's survival had been notably prolonged and Carter 
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(1972) postulated that maybe IV treatment on its own, but at a higher 
dosage rate, may be successful in further cases. This was in fact proved 
in a later case (Anderson and Jamieson, 1972). 
The second British case, a brother of case one,was admitted 
to hospital two days after case one, complaining of a headache and sore 
throat with neck pains. In view of patient one, amphotericin Band 
sulphadiazine treatment was begun although the CSF was clear . By day 
seven he was symptom clear though on day eight they returned and 
although the CSF was clear, some amebae were cultured which appeared to 
be similar to those from case one. Amphotericin B was given, 0.25mg.kg-l 
IV over four hours increasing to 0.75mg .kg-1 after four days for a 
total of 10 days after which the CSF was clear and no amebae were 
cultured. He was discharged symptom free. 
The third case was admi_tted to hospital six days after case 
one. He complained of sore throat, headache, vomiting and abdominal 
pain although CSF appeared normal . He was given amphotericin Band 
sulphadiazine though signs of drug toxicity were noted after four days 
and the treatment was stopped. It was on day eight that the growth of 
amebae from case two was reported and although the patient was well, 
amphotericin B treatment was recorrnnended at 0.25mg . kg- 1 . He was 
dischar ged after fourteen days, symptom free with no amebae having been 
isolated at any time (Apley et 2. l., 1970). "Case three must be 
considered to be only doubtful ly infected with Amebae" (Apley et al., 
1970). Griffin (1976) has disputed the dia gnosis of Naegleria meningo-
encephalitis in cases one and two and believes that Acanthamoeba were 
in fact the ameba involved,and that sulphadiazine was responsible for 
the treatment of case two and the prolonged survival in case one. He 
also considers that the leve l of sulphadiazine in the CSF prevented the 
growth of amebae in culture. 
Pan and Ghosh (19 71) r eported the survival of two children 
(aged 6 months and 3 years) with CNS infections of slow onset (3-5 
months). CSF samples showed "motile amebae with thin pseudopods" and, 
although no strains were isolated, treatment was with amphotericin B, 
sulphadiazine and intrathecal steroids . These two cases are considered 
inconclusive in the nature of the etiological agent involved and the 
effective agent in their treatment (Donald, 1979). 
The first successful treatment of N. fowleri PAM was that 
reported by Anderson and Jamieson (1972). A fourteen year old boy from 
Queensland was in the fourth day of illness and comatose by the time 
treatment was be gun. N. fowleri was cultured from the CSF, in 
which they could be plainly seen. Amphotericin B was given at a dose 
of lmg,kg-l per day IV, as well as penicillin,-ampicillin and 
sulphadiazine which he had been having for three days previously. He 
was afebrile and talking rationally within two days. After five days 
the CSF white cell count had dropped but amebae were still seen, 
therefore amphotericin B was given intrathecally (IT) and later I.vent. 
in small doses (0.1mg on alternate days). The fluid gradually cleared 
and he was discharged from hospital without any neurological defects. 
The second successful treatment of a N. fowleri PAM case 
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is that of a nine year old female from Torrance, California who showed 
typical symptoms of meningo-encepha litis three days before admission to 
hospital (Seidel et al., pers. comm,). Routine CSF cell count procedures 
revealed organisms with ameboid movements and the following medications 
were given: amphotericin B - 1.5mg IT and lmg.kg-l IV; sulphadiazine 
50mg.kg-l IV; chloramphenicol 25mg.kg-l IV and penicillin 3.4 x 105 units 
IV, The patient was then transferred to Harbor General Hospital where 
she was in a coma on admission but responsive to pain and tactile 
stimulation. The following treatment was administered: 
(i) Amphotericin B was given IV at a dose of 1.Smg .kg-1 .day-l 
given in two doses daily for three days after which it was 
decreased to lmg.kg- 1 .day-l given in a single daily dose for 
six days. 
(ii) Amphotericin B was also given IT at l.Smg.day-l for two 
days after which it was decreased to 1,0mg every other day 
for eight days. This was administered through a lumbar 
intrathecal catheter. 
(iii) Miconazole was given IV at a dose of 350mg,m-2 ,day-l given 
thrice daily for nine days. 
(iv) Miconazole IT at lOmg.day- 1 for two days then 10mg every 
other day for eight days • 
. (v) Rifampin was given orally at a dose of lOmg.kg- 1 .day-l 
thrice daily for nine days. 
Sulphadiazine (IV - 4gms.day-1) was continued for three days 
until studies confirmed the diagnosis of Naegleria meningo-encephalitis. 
Penicillin and chloramphenicol were continued for three days until CSF 
cultures were shown to be negative for bacteria. Dexamethasone and 
diphenylhydantoin were given for increased intracranial pressure and 
seizure activity respectively. The· patient stabilized clinically over 
16 
the first forty eight hours. Gradually over the next month of 
hospitalization her mental status improved and no significent neurological 
deficits were noted at discharge (Seidel et al., -pers. comm). 
In other reported cases of PAM where there was proof of 
N. fowleri infection, and where amphotericin B was given as a treatment, 
the course of the disease was often too advanced to see any effect 
(Van Den Driessche et al., 1973; Donald, 1979). 
Amebic meningitis due to Acanthamoeba are a lot less common 
than those of Naegleria probably due to the need for some predisposing 
factor (Martinez et al., 1977; Kernohan et al., 1960; Jager and Stamm, 
1972; Bhagwandeen et al. ,1975). Callicott et al. (1968) reported a 
survival due to A. astronyxis which was isolated from the CSF although 
the authors were unable to provide evidence as to whether the disease 
was in fact due to Aca nthamoeba. 
Several cases of Acanthamoeba infection have been reported 
though only after post-mortem examination where the brain sections were 
stained by indirect immunofluorescent antibody techniques (Ringsted 
et al., 1976; Martinez et al., 1977; Hof fmann et al., 1978; Willaert, 
1978). 
A possible case was reported b y Kenney (1971) in a patient 
hospitalized for acute gastritis of unknown origin. Compliment 
fixation tests revealed no antibodies to Entamoeba histolytica though 
did reveal some to A. culbertsoni which rose over the next two months. 
Clinical examination failed to reveal any symptoms of cerebral 
involvement and the patient refused a spinal tap. The patient was put 
onto antiamebic treatment consisting of dehydro-emetine and chloroquine 
(IM). Compliment fixation tests two months later showed that the serum 
titre had decreased. 
The only human Acanthamoeba i n f ections positively diagnosed 
during life were those in the eye. Nagi ngton et al. (1974) repeatedly 
isolated Acanthamoeba from two English pa tients with corneal ulcers. 
Warhurst and Thomas (1975) identified the amebae as A. castellanii and 
A. polyphaga. In one case, chloramphenicol, iodoxuridine, 3-fluor-
thymidine, methicillin, gentamicin and later sulphadiazine were tried 
without any effect. After six months, because of corneal ulceration, 
pain and loss of vision, a corneal graft was performed which was rejected. 
The other infection was in a 59 year old farmer with an identical 
condition which required enucleation of the eye after one year. 
Treatment was in this case, chloramphenicol, acetylcysteine, 3-fluoro-
thymidine and clotrimazole. 
At the same time as the above eye infections, Jones et al. (1975) 
cultivated A. polyphaga from corneal ulcers of two patients in Houston, 
Texas. They reported suppression of the ameba e with paromomycin. It 
seems that these infections may not be so rare, and in cases of chronic 
corneal ulceration, amebic infection should always be considered 
(Nagington et al., 1974). 
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